New data from the National Agency for the Control of AIDS (NACA) reveals that over two million Nigerians are currently living with HIV, with Rivers, Benue, and Akwa Ibom states topping the list of high-prevalence areas.
According to the 2024 HIV Spectrum Estimates, Rivers State leads the chart with 208,767 recorded cases. Benue follows with 202,346 cases, while Akwa Ibom ranks third with 161,597 cases.
Lagos State, Nigeria’s commercial hub, is fourth with 108,649 people living with HIV. Anambra State follows with 100,429, and the Federal Capital Territory records 83,333 cases—making it the highest in the North Central zone.
Oyo State reported 50,063 HIV cases, placing it in the mid-range bracket along with Plateau (51,736), Borno (50,433), Cross River (43,452), Ogun (43,348), and Nasarawa (44,993). Other notable figures include Delta (68,170), Imo (67,944), Enugu (61,028), and Edo (60,095).
States like Abia (54,655), Kaduna (54,458), and Kano (53,972) also show significant prevalence. Adamawa reported 40,059 cases, while Osun (30,714), Niger (29,756), Bauchi (28,698), and Kogi (28,421) fall into the lower tier.
The states with the lowest reported cases include Kwara (20,259), Kebbi (19,339), Ekiti (18,857), Sokoto (15,223), Ebonyi (14,151), Zamfara (13,253), and Yobe (11,956).
In terms of HIV-related deaths, an estimated 43,683 Nigerians died last year—28,589 adults (13,650 males and 14,939 females) and 15,094 children under 14 years.
Currently, 1,753,425 people living with HIV in Nigeria know their status. Of these, 1,693,457 are adults (579,209 males and 1,114,401 females), and 54,983 are children.
Access to antiretroviral treatment has seen a notable improvement, with 1,735,808 individuals on therapy—1,690,057 adults (577,632 males and 1,112,425 females), and 45,751 children.
Among those receiving treatment, 1,160,256 were tested for viral suppression, and 1,112,339 were confirmed to have suppressed viral loads—this includes 1,083,177 adults and 29,162 children.
Despite progress in treatment, a significant gap remains in preventing mother-to-child transmission. Of the 93,186 pregnant women identified as needing antiretroviral therapy, only 31,095 received it.